What is the current Price Target for the Alzamend Neuro Inc stock?

The average Alzamend Neuro Inc target price is $20.00. This is 1,860.78% higher than the current stock price. 1 Analyst has issued a Alzamend Neuro Inc price target 2026.

How high will the Alzamend Neuro Inc stock rise?

No reliable answer can be given as to how high the Alzamend Neuro Inc stock will rise. The performance of stocks, including the Alzamend Neuro Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Alzamend Neuro Inc stock today?

The performance of Alzamend Neuro Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Alzamend Neuro Inc stock fall?

The decline in Alzamend Neuro Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Alzamend Neuro Inc Forecast, price target & analysts

$1.02

1.92% yesterday

Nasdaq, Apr 03, 10:00 pm CET

ISIN

US02262M3088

Symbol

ALZN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Alzamend Neuro Inc Target price 2025 - Analyst rating & recommendation

Alzamend Neuro Inc Classifications & Recommendation:

Buy

50%

Hold

50%

Alzamend Neuro Inc Price Target

Target Price	$20.00
Price	$1.02
Potential	1,860.78% register free of charge
Number of Estimates	1

	1 Analyst has issued a Alzamend Neuro Inc price target 2026. The average Alzamend Neuro Inc target price is $20.00. This is 1,860.78% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 1 Analysts recommend Alzamend Neuro Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Alzamend Neuro Inc stock has an average upside potential 2026 of 1,860.78% register free of charge . Most analysts recommend the Alzamend Neuro Inc stock at Buy or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Apr '24	2025 Estimates
Earnings Per Share $	-14.70	-1.90
	35.78%	87.07%
P/E		negative

1 Analysts have issued a Alzamend Neuro Inc forecast for earnings per share. The average Alzamend Neuro Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-14.70	35.78%
2025	$-1.90 87.07% Unlock
2026	$-0.75 60.53% Unlock
2027	$-0.81 8.00% Unlock
2028	$-0.78 3.70% Unlock
2029	$-0.19 75.64% Unlock

Current	-0.33	37.74%
2025	-0.54 63.64% Unlock
2026	-1.36 151.85% Unlock
2027	-1.26 7.35% Unlock
2028	-1.31 3.97% Unlock
2029	-5.37 309.92% Unlock

Alzamend Neuro Inc...

Current Alzamend Neuro Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Ascendiant Capital	Locked ➜ Locked	Locked	Mar 17 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Dec 16 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Nov 11 2024

Analyst Rating	Date
Locked Ascendiant Capital: Locked ➜ Locked	Mar 17 2025
Locked Ascendiant Capital: Locked ➜ Locked	Dec 16 2024
Locked Ascendiant Capital: Locked ➜ Locked	Nov 11 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now